Clinicians should have a standard approach for discussing the risk of adverse events associated with immune checkpoint inhibitors, researchers say.

The most common sites for melanoma are areas of the body that receive the most sunlight like the face, scalp, ears, neck, and hands ... before the cancer has spread to the lymph nodes. Hodgkin ...

Three Fred Hutch Cancer Center researchers received a five-year, $3.8 million award from the National Cancer Institute to ...

Enphase Energy Inc. $61.84 2.32 3.90% ...